Assessment of flexible bronchoscopy in lung cancer: Audit of practice and diagnostic rate

A. H. Mansur, R. M. Cayton, S. P. Burge (Stoke-on-Trent, Birmingham, United Kingdom)

Source: Annual Congress 2002 - Lung cancer: epidemiology and clinical characteristics
Session: Lung cancer: epidemiology and clinical characteristics
Session type: Thematic Poster Session
Number: 573
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

Flexible bronchoscopy role in the diagnosis of lung cancer is studied at a large teaching hospital. The aim is to assess the overall performance and variation among bronchoscopists or pathologists in establishing the diagnosis. We studied 429 bronchoscopic procedures performed on 368 patients with eventual diagnosis of lung cancer [109 females (25.4%), mean age 70 years]. Bronchoscopy confirmed diagnosis of lung cancer in 286 cases (67%). We classified all cases into four groups according to the endoscopic finding. These include definite visible tumour(DVT)188, possible tumour(PT) 112, no tumour seen 54 or unknown 63. In the DVT group, bronchial biopsies confirmed carcinoma in 75% of cases, whilst bronchial brushings and washings together were positive in 27% of cases. The combination of histology and cytology confirmed lung cancer diagnosis in 81.9% of cases. In contrast, the overall diagnostic rate in the PT was low at 50.5%. Performance of bronchoscopists was assessed by comparing the number and type of specimens collected and the diagnostic yield. Together, bronchoscopists collected 910 specimens (217 endobronchial biopsies, 666 bronchial brushings and washings, and 27 unknown). Using chi-square test, we observed no statistical difference between bronchoscopists in bronchial biopsy or cytological specimen rate (p=0.6). There was no significant difference in the diagnostic yield of different bronchoscopists (p=0.8). The pattern of reporting of histological and cytological specimens by five pathologists was similar. The histological spectra is in keeping with published data, where we observed 41% squamous cell, 8% adenocarcinoma, 18% anaplastic tumour, 18% small cell. The remained 15% were labelled as non-small cell.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. H. Mansur, R. M. Cayton, S. P. Burge (Stoke-on-Trent, Birmingham, United Kingdom). Assessment of flexible bronchoscopy in lung cancer: Audit of practice and diagnostic rate. Eur Respir J 2002; 20: Suppl. 38, 573

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnostic accuracy of flexible bronchoscopy for lung cancer diagnosis in an expert center
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018


Audit of adherence to NICE guidelines on investigation of lung cancer – CT before bronchoscopy
Source: Eur Respir J 2007; 30: Suppl. 51, 665s
Year: 2007

The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards
Source: Eur Respir J 2001; 18: Suppl. 33, 62s
Year: 2001

Integration of interventional bronchoscopy in the management of lung cancer
Source: Eur Respir Rev 2015; 24: 378-391
Year: 2015



Conventional TBNA – A underutilized but valuable technique during bronchoscopy in comparsion with other conventional diagnostic techniques (CDTs) in diagnosing lung malignancies
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013


Accuracy of endobronchial ultrasound (EBUS) for evaluation of N2/3 disease in lung cancer: Experience over six years
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014

Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013


Validating an EBUS service provided by a group of operators with different levels of experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Diagnostic value of conventional transbronchial needle aspiration without an on-site cytopathologist: Experience of 363 procedures
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015

Combined endobronchial and endoscopic ultrasound-guided needle aspiration performed by single ultrasound bronchoscopevs routine videobronchoscopy for diagnosis of advanced lung cancer – A prospective study
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016


Increased diagnosis rates using ultrathin bronchoscopy and thin bronchoscopy with the EBUS-guide sheath method with virtual bronchoscopic navigation assistance
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013


Learning curves for ultrasound guided lung biopsy in the hands of respiratory physicians
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016


Improvement in endoscopic diagnosis of lung cancer by narrow-band imaging (NBI)
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Post-bronchoscopy sputum in the current bronchoscopy technique dose not improve the diagnostic yield in thoracic malignancies
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Ultrasound guided transthoracic biopsy performed by respiratory physicians: Diagnostic yield and complications
Source: International Congress 2015 – Transbronchial and percutaneous approach to peripheral pulmonary lesions
Year: 2015


Computed tomographic screening for lung cancer: individualising the benefit of the screening
Source: Eur Respir J 2007; 30: 843-847
Year: 2007



Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Evaluation of lung cancer diagnoses made by bronchoscopy despite EBUS findings being invisible
Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks
Year: 2017